The use of complementary and alternative medicines among patients with locally advanced breast cancer - A descriptive study

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Helyer, Lucy K ^a   Chin, Stephen ^a   Chui, Betty K ^a   Fitzgerald, Barbara ^a   Verma, Sunil ^a   Rakovitch, Eileen ^b   Dranitsaris, George ^b   Clemons, Mark ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MULTIVITAMIN;

ACUPUNCTURE; ADULT; ADVANCED CANCER; AGE; AGED; ALTERNATIVE MEDICINE; ANXIETY; ARTICLE; ASIAN; BREAST CANCER; BREAST SURGERY; CANADA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CHIROPRACTIC; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; DISEASE SEVERITY; ETHNOLOGY; FEMALE; GUIDED IMAGERY; HEALING; HEALTH BELIEF; HEALTH SURVEY; HOMEOPATHY; HUMAN; HYPNOSIS; IMMUNOMODULATION; MARRIAGE; MASSAGE; MEDICAL RESEARCH; MEDITATION; OUTCOMES RESEARCH; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RELIGION; RISK ASSESSMENT; SCORING SYSTEM; SOCIOECONOMICS; TAI CHI; VITAMIN SUPPLEMENTATION; YOGA;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; MOTIVATION; NEOPLASM STAGING; PERCEPTION; RISK FACTORS;

EID: 33744926409     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-39     Document Type: Article

References (31)

1. Eisenberg DM, Kessler RC, Forster C, Norlock FE, Calkins DR, Deldano TL: Unconventional medicine in the United States; prevalence, costs and patterns of use. N Engl J Med 1993, 328:246-252.
2. Boon H, Stewart M, Kennard MA, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: The use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000, 18:2515-2521.
3. Burstein HJ, Gelber S, Guadagnoli E, Weeks J: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999, 340:1733-1739.
4. Ashikage T, Bosompra K, O'Brien P, Nelson L: Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Supp Care Can 2002, 10:542-548.
5. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE: Complementary/alternative medicine use in a comprehensive cancer centre and the implications of oncology. J Clin Oncol 2000, 18:2505-2514.
6. Ernst E, Casselith BR: The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998, 83(4):777-782.
7. Astin JA: Why patients use alternative medicine: Results of a national study. JAMA 1998, 279:1548-1553.
8. Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti: The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Can 1998, 33:324-328.
9. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C: Prevalence of complementary therapy use by women with breast cancer: a population - based study. E J Cancer 2000, 36:1359-1364.
10. Jacobson JS, Workman S, Kronenberg F: Research on complementary/ alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 2000, 18:668-683.
11. Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, Shekelle P: Use of complementary/alternative therapies by women with advanced stage breast cancer. BMC Complementary and Alternative Medicine 2002, 2:8.
12. Singletary SE, Allred C, Ashley P, Bassett W, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand S, Green FL: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002, 20:3628-3636.
13. Therasse P, Mauriac L, Welnicka-Jaskiewicz M, Bruning P, Cufer T, Bonnefoi H, Tomiak E, Pritchard KI, Hamilton A, Piccart MJ, EORTC: Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study. J Clin Oncol 2003, 21(5):843-50.
14. Rakovitch E, Pignol J, Chartier C, Ezer M, Verma S, Dranitsaris G, Clemons M: Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Research and Treatment 2005, 90:139-148.
15. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67(6):361-70.
16. Hopwood P, Howell A, Maguire P: Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 1991, 64(2):353-6.
17. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD: The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. B J C 1999, 79(5/6):858-864.
18. Malik IA, Gopalan S: Use of CAM results in delay in seeking medical advice for breast cancer. Eur J Epidemiol 2003, 18:817-822.
19. Mills E, Ernst E, Singh R, Ross C, Wilson K: Health food store recommendations: implications for breast cancer patients. Breast Cancer Res 2003, 5:170-174.
20. Hisham AN, Yip CH: Overview of breast cancer in Malaysian women: A problem with late diagnosis. Asian J Surg 2004, 27:130-133.
21. Mohamed I, Williams K, Tamburrino M, Wryobeck J, Carter S: Understanding locally advanced breast cancer: what influences a woman's decision to delay treatment? Prev Med 2005, 41:399-405.
22. Ramirez A, Westcombe A, Burgess C, Sutton S, Littlejohns P, Richards M: Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999, 9159:1127-1131.
23. Deng G, Cassileth B: Integrative oncology: complementary therapies for pain, anxiety and mood disturbance. CA Cancer J Clin 2005, 55:109-116.
24. Anon: Integration of behavioural and relaxation approaches into the treatment of chronic pain and insomnia. NIH technology assessment panel on integration on behavioral and relaxation approaches into the treatment of chronic pain and insomnia. JAMA 1996, 276:313-318.
25. Moschen R, Kemmler G, Schweigkofler H, Holzner B, Dunser M, Richter R, Fleischhacker WW, Sperner-Unterweger B: Use of alternative/complementary therapy in breast cancer patients a psychological perspective. Support Care Cancer 2001, 9:267-274.
26. Cui Y, Shu X, Gao Y, Wen W, Ruan Z, Jin F, Zheng W: Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Research and Treatments 2004, 85:263-270.
27. Patterson R, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM: Types of alternative medicine used by patients with breast cancer, or prostate cancer: predictors, motives and costs. J Altern and Complement Med 2004, 8:477-485.
28. Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA: An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004, 22:671-677.
29. Lee M, Lin S, Wrensch M, Adler S, Eisenberg D: Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 2000, 92(1):42-47.
30. Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA: Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004, 23:4810-4815.
31. Nagel G, Hoyer H, Katenkamp D: Use of complementary and alternative medicine by patients with breast Cancer: observations from a health survey. Supp Care Cancer 2004, 12(11):789-796.